The landscape of managing diabetes is advancing with the arrival of transdermal GLP-1 delivery . These innovative devices offer a potentially less invasive alternative to injections for individuals managing type 2 diabetes . They deliver a GLP-1 agonist directly through the epidermis, circumventi